The Role of NKG2D and Its Ligands in Autoimmune Diseases: New Targets for Immunotherapy
Natural killer (NK) cells and CD8<sup>+</sup> T cells can clear infected and transformed cells and generate tolerance to themselves, which also prevents autoimmune diseases. Natural killer group 2 member D (NKG2D) is an important activating immune receptor that is expressed on NK cells,...
Main Authors: | Leiyan Wei, Zhiqing Xiang, Yizhou Zou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/24/17545 |
Similar Items
-
Association of psoriasis with autoimmune disorders: Results of a pilot study
by: Sanket Vashist, et al.
Published: (2020-01-01) -
Antigen-based immunotherapy for autoimmune disease: current status
by: Hirsch DL, et al.
Published: (2014-12-01) -
Dual autoimmune diseases: Rheumatoid arthritis with systemic lupus erythematosus and Type 1 diabetes mellitus with multiple sclerosis
by: Rizwan Ahmad, et al.
Published: (2022-09-01) -
Intestinal Microbes in Autoimmune and Inflammatory Disease
by: Wan-Jung H. Wu, et al.
Published: (2020-12-01) -
Sarcopenia in Autoimmune and Rheumatic Diseases: A Comprehensive Review
by: Hyo Jin An, et al.
Published: (2020-08-01)